Third Generation Anti-Pseudomonal CephalosporinsAka: Third Generation Anti-Pseudomonal Cephalosporins, Ceftazidime
- See Also
- Preparations: Ceftazidime (Fortaz)
- Adult: 1-2 grams IM or IV every 8 to 12 hours
- Child: 30-50 mg/kg IV every 8 hours
- Most expensive
- Limited spectrum
|Definition (NCI)||A beta-lactam, third-generation cephalosporin antibiotic with bactericidal activity. Ceftazidime binds to and inactivates penicillin-binding proteins (PBP) located on the inner membrane of the bacterial cell wall. PBPs participate in the terminal stages of assembling the bacterial cell wall, and in reshaping the cell wall during cell division. Inactivation of PBPs interferes with the cross-linkage of peptidoglycan chains necessary for bacterial cell wall strength and rigidity. This results in the weakening of the bacterial cell wall and causes cell lysis. Compared to the second and first generation cephalosporins, ceftazidime is more active against gram-negative bacteria and less active against gram-positive bacteria. Ceftazidine also crosses the blood-brain barrier and reaches therapeutic concentrations in the central nervous system (CNS).|
|Definition (MSH)||Semisynthetic, broad-spectrum antibacterial derived from CEPHALORIDINE and used especially for Pseudomonas and other gram-negative infections in debilitated patients.|
|Concepts||Antibiotic (T195) , Organic Chemical (T109)|
|SnomedCT||323836005, 36893000, 387200005|
|English||Ceftazidime, Pyridinium, 1-((7-(((2-amino-4-thiazolyl)((1-carboxy-1-methylethoxy)imino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-, inner salt, pentahydrate, (6R-(6alpha,7beta(Z)))-, ceftazidime, ceftazidime (medication), CEFTAZIDIME, Ceftazidime [Chemical/Ingredient], cefTAZidime, CefTAZidime, Pyridinium, 1-((7-(((2-amino-4-thiazolyl)((1-carboxy-1-methylethoxy)imino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-, Hydroxide, Inner Salt, Pentahydrate, (6R-(6alpha,7beta(Z)))-, Ceftazidime (product), Ceftazidime (substance)|
|Spanish||ceftazidima (producto), ceftazidima (sustancia), ceftazidima, Ceftazidima|
Derived from the NIH UMLS (Unified Medical Language System)
You are currently viewing the original 'fpnotebook.com\legacy' version of this website. Internet Explorer 8.0 and older will automatically be redirected to this legacy version.
If you are using a modern web browser, you may instead navigate to the newer desktop version of fpnotebook. Another, mobile version is also available which should function on both newer and older web browsers.
Please Contact Me as you run across problems with any of these versions on the website.